Stock listing
NASDAQ:PDSB PDS Biotechnology Corporation Stock
Home listing (NASDAQ) of PDS Biotechnology Corporation
Follow PDS Biotechnology Corporation into a list and get an email when it puts out news.
Share price · NASDAQ:PDSB
$1.44 USD -0.11 (-7.1%)
Close on Oct 30, 2026
- Day range
- $1.33 – $1.55 USDOct 30, 2026
- Volume
- 5.39M sharesOct 30, 2026
- Market cap
- $151.2M USDAt the close on Oct 30, 2026 · price × 105.0M shares outstanding
- 52-week range
- $0.195 – $1.79 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $16.07M USDMedian day 4.48M shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:PDSB · Home | $1.44 USD | -0.11 (-7.1%) | 5,391,417 | $1.49 | $1.55 | $1.33 | $1.55 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:PDSB · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.44 | -0.11 | -7.1% | $1.49 | $1.55 | $1.33 | 5,391,417 | |
| $1.55 | +0.03 | +2.0% | $1.53 | $1.70 | $1.52 | 8,105,687 | |
| $1.52 | +0.22 | +16.9% | $1.29 | $1.605 | $1.28 | 15,086,505 | |
| $1.30 | +0.235 | +22.1% | $1.06 | $1.39 | $1.04 | 10,597,699 | |
| $1.065 | -0.045 | -4.1% | $1.10 | $1.10 | $1.033 | 2,244,136 | |
| $1.11 | -0.05 | -4.3% | $1.11 | $1.13 | $1.06 | 2,700,300 | |
| $1.16 | -0.08 | -6.5% | $1.16 | $1.22 | $1.115 | 5,122,600 | |
| $1.24 | +0.279 | +29.0% | $0.998 | $1.31 | $0.99 | 15,240,000 | |
| $0.961 | +0.044 | +4.8% | $0.93 | $0.986 | $0.90 | 4,092,800 | |
| $0.917 | -0.213 | -18.8% | $1.13 | $1.14 | $0.917 | 8,424,400 | |
| $1.13 | -0.17 | -13.1% | $1.25 | $1.26 | $1.09 | 6,935,800 | |
| $1.30 | -0.11 | -7.8% | $1.371 | $1.39 | $1.095 | 10,232,700 | |
| $1.41 | -0.19 | -11.9% | $1.60 | $1.67 | $1.38 | 9,457,700 | |
| $1.60 | +0.08 | +5.3% | $1.43 | $1.79 | $1.39 | 16,967,400 | |
| $1.52 | +0.14 | +10.1% | $1.485 | $1.55 | $1.38 | 15,076,400 | |
| $1.38 | +0.36 | +35.3% | $1.04 | $1.40 | $1.00 | 16,062,000 | |
| $1.02 | -0.045 | -4.2% | $1.04 | $1.10 | $0.96 | 4,875,800 | |
| $1.065 | +0.02 | +1.9% | $1.05 | $1.10 | $1.00 | 5,604,600 | |
| $1.045 | -0.155 | -12.9% | $1.15 | $1.27 | $0.936 | 17,042,600 | |
| $1.20 | +0.451 | +60.2% | $0.781 | $1.35 | $0.769 | 78,550,900 | |
| $0.749 | +0.043 | +6.1% | $0.715 | $0.75 | $0.709 | 3,656,800 | |
| $0.706 | -0.045 | -6.0% | $0.75 | $0.76 | $0.70 | 3,726,200 | |
| $0.751 | +0.008 | +1.1% | $0.724 | $0.761 | $0.71 | 4,585,600 | |
| $0.743 | -0.023 | -3.0% | $0.751 | $0.77 | $0.729 | 2,706,400 | |
| $0.766 | -0.031 | -3.9% | $0.781 | $0.79 | $0.728 | 4,042,400 | |
| $0.797 | -0.003 | -0.4% | $0.804 | $0.822 | $0.781 | 3,937,400 | |
| $0.80 | -0.024 | -2.9% | $0.81 | $0.81 | $0.75 | 6,097,400 | |
| $0.824 | -0.086 | -9.5% | $0.88 | $0.906 | $0.818 | 9,724,200 | |
| $0.91 | +0.068 | +8.1% | $0.86 | $0.995 | $0.812 | 24,750,000 | |
| $0.842 | +0.036 | +4.5% | $0.937 | $0.97 | $0.807 | 17,073,200 | |
| $0.806 | -0.036 | -4.3% | $0.823 | $0.90 | $0.751 | 18,976,900 | |
| $0.842 | -0.149 | -15.0% | $0.908 | $0.998 | $0.82 | 35,878,100 | |
| $0.991 | +0.406 | +69.4% | $0.649 | $1.06 | $0.62 | 196,516,300 | |
| $0.585 | +0.186 | +46.6% | $0.492 | $0.755 | $0.413 | 372,179,900 | |
| $0.399 | +0.104 | +35.3% | $0.278 | $0.45 | $0.261 | 80,847,300 | |
| $0.295 | -0.02 | -6.3% | $0.32 | $0.32 | $0.293 | 5,839,200 | |
| $0.315 | +0.022 | +7.5% | $0.291 | $0.33 | $0.285 | 12,732,500 | |
| $0.293 | -0.007 | -2.3% | $0.30 | $0.318 | $0.285 | 19,253,100 | |
| $0.30 | +0.08 | +36.4% | $0.488 | $0.651 | $0.257 | 491,124,600 | |
| $0.22 | 0.00 | 0.0% | $0.22 | $0.238 | $0.217 | 1,083,600 | |
| $0.22 | +0.008 | +3.8% | $0.215 | $0.23 | $0.207 | 832,600 | |
| $0.212 | +0.008 | +3.9% | $0.201 | $0.218 | $0.201 | 765,000 | |
| $0.204 | -0.01 | -4.7% | $0.21 | $0.21 | $0.197 | 591,500 | |
| $0.214 | +0.003 | +1.4% | $0.21 | $0.232 | $0.206 | 1,353,300 | |
| $0.211 | -0.007 | -3.2% | $0.215 | $0.225 | $0.208 | 837,700 | |
| $0.218 | -0.005 | -2.2% | $0.224 | $0.234 | $0.214 | 1,242,800 | |
| $0.223 | +0.002 | +0.7% | $0.223 | $0.226 | $0.215 | 1,197,600 | |
| $0.222 | +0.005 | +2.2% | $0.219 | $0.229 | $0.217 | 1,185,908 | |
| $0.217 | -0.002 | -1.0% | $0.219 | $0.222 | $0.207 | 697,412 | |
| $0.219 | +0.01 | +4.8% | $0.208 | $0.236 | $0.208 | 2,933,100 | |
| $0.209 | +0.008 | +4.0% | $0.203 | $0.218 | $0.198 | 2,008,700 | |
| $0.201 | -0.007 | -3.4% | $0.207 | $0.24 | $0.195 | 3,758,600 | |
| $0.208 | -0.013 | -5.9% | $0.221 | $0.225 | $0.208 | 1,038,600 | |
| $0.221 | -0.01 | -4.3% | $0.23 | $0.23 | $0.211 | 1,817,700 | |
| $0.231 | -0.002 | -0.9% | $0.23 | $0.244 | $0.225 | 1,747,300 | |
| $0.233 | -0.009 | -3.7% | $0.242 | $0.246 | $0.217 | 4,384,200 | |
| $0.242 | -0.015 | -5.8% | $0.26 | $0.272 | $0.23 | 7,116,900 | |
| $0.257 | -0.474 | -64.8% | $0.678 | $0.678 | $0.231 | 28,273,600 | |
| $0.731 | -0.044 | -5.7% | $0.77 | $0.80 | $0.707 | 197,100 | |
| $0.775 | +0.028 | +3.7% | $0.74 | $0.80 | $0.74 | 225,600 | |
| $0.747 | +0.02 | +2.8% | $0.75 | $0.76 | $0.727 | 408,000 | |
| $0.727 | +0.007 | +1.0% | $0.728 | $0.731 | $0.701 | 171,700 | |
| $0.72 | +0.006 | +0.8% | $0.72 | $0.763 | $0.72 | 291,900 | |
| $0.714 | +0.028 | +4.1% | $0.69 | $0.738 | $0.69 | 248,200 | |
| $0.686 | -0.013 | -1.9% | $0.695 | $0.703 | $0.671 | 163,800 | |
| $0.699 | +0.029 | +4.3% | $0.67 | $0.699 | $0.66 | 124,700 |
- Ticker
- NASDAQ:PDSB
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 20, 2026
PDS Biotechnology Appoints Three Accomplished Pharma Industry Executives to Board of Directors
Latest earnings call · May 13, 2026
PDS Biotechnology (NASDAQ:PDSB) Q1 2026 Earnings Call
Replay and transcript
Latest deck · Oct 21, 2026
Investor Presentation (October 2026)
Investor deck · 28 slides
Calls
Replays
PDS Biotechnology (NASDAQ:PDSB) Q1 2026 Earnings Call
Wed, May 13, 2026 · 8:00 AM ET
Watch TranscriptPDS Biotechnology (NASDAQ:PDSB) Q4 2025 Earnings Call
Mon, Mar 30, 2026 · 8:00 AM ET
Watch TranscriptPDS Biotechnology (NASDAQ:PDSB) Q3 2025 Earnings Call
Thu, Nov 13, 2025 · 8:00 AM ET
Watch Transcript
Latest news
PDS Biotechnology Appoints Three Accomplished Pharma Industry Executives to Board of Directors
Oct 20, 2026
Closed $0.961 (+4.8%) on Oct 20, 2026
PDS Biotech to Host Key Opinion Leader Event on PDS0301 for the Treatment of Advanced Colorectal Cancer with Liver Metastases
Oct 6, 2026
Closed $1.05 (-12.9%) on Oct 6, 2026
PDS Biotech Announces Publication of VERSATILE-002 Phase 2 Clinical Trial Results of PDS0101 with pembrolizumab in HPV16-Positive Recurrent and/or Metastatic (R/M) Head and Neck Cancer in JAMA Oncology
Sep 22, 2026
Closed $0.91 (+8.1%) on Sep 22, 2026
PDS Biotech Announces Initial Closing of up to $22.3 Million PIPE Financing and the Appointment of Dr. Patrick Soon-Shiong to Its Board of Directors
Sep 14, 2026
Closed $0.399 (+35.3%) on Sep 14, 2026
PDS Biotech Announces up to $22.55 Million Financing Led by Dr. Patrick Soon-Shiong, Founder of NantWorks
Sep 8, 2026
Closed $0.30 (+36.4%) on Sep 8, 2026
PDS Biotech Reports Second Quarter 2026 Financial Results
Aug 13, 2026
Closed $0.233 (-3.7%) on Aug 13, 2026
PDS Biotech Announces Strategic Refocus Prioritizing PDS0301 in Metastatic Colorectal Cancer (mCRC) and Partnership Strategy for PDS0101
Aug 11, 2026
Closed $0.257 (-64.8%) on Aug 11, 2026
PDS Biotech Reports First Quarter 2026 Financial Results and Provides Clinical Programs and Corporate Update
May 13, 2026
Closed $1.33 (+20.9%) on May 13, 2026
PDS Biotech Announces Conference Call and Webcast for 2026 First Quarter Financial Results
May 6, 2026
Closed $1.06 (0.0%) on May 6, 2026
Financings
Private placement of units of common stock or pre-funded warrants with common warrants
Sep 14, 2026
Tranche closed: US$11.3M raised · US$0.2825 a unit · a Common Warrant to purchase one-half of one Private Placement Share
Buyers: Nant Capital, LLC (Led the round; obligated to purchase $10,000,000 at the Milestone Closing); AB Group Ltd. (Obligated to purchase $1,000,000 at the Milestone Closing)
Use of proceeds: Repay outstanding indebtedness, working capital and general corporate purposes, including clinical development, R&D and G&A expenses
Decks
Investor Presentation (October 2026)
Investor deck · 28 slides · Oct 21, 2026
Investor Presentation (September 2026)
Investor deck · 28 slides · September 2026
Q1 2026 Earnings Presentation
Earnings · 21 slides · May 13, 2026
Investor Presentation (April 2026)
Investor deck · 21 slides · Apr 24, 2026
PDS Biotechnology Corporation on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 22 in the last 12 months · 234 in all · newest Oct 20, 2026 · oldest 2019
- Calls
- 18 calls with a replay · 18 with a transcript · latest May 13, 2026
- Decks
- 74 decks · latest Oct 21, 2026
Where PDS Biotechnology Corporation is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:PDSB · Home listing · This page | NASDAQ | United States | USD |
| LS Exchange:A2PF3F | LS Exchange | Germany | EUR |
| gettex:EU6 | gettex | Germany | EUR |
| Lang & Schwarz:A2PF3F | Lang & Schwarz | Germany | EUR |
| Tradegate:EU6 | Tradegate | Germany | EUR |
| BOATS:PDSB | BOATS | United States | USD |
| Frankfurt:EU6 | Frankfurt | Germany | EUR |
| Dusseldorf:EU6 | Dusseldorf | Germany | EUR |
| Hamburg:EU6 | Hamburg | Germany | EUR |
| Munich:EU6 | Munich | Germany | EUR |
| Stuttgart:EU6 | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about PDS Biotechnology Corporation.